Phoenestra produces high-quality stem cells (so-called human induced pluripotent stem cells (hiPSCs)) that are used directly or indirectly for the development of novel drugs and therapies. Phoenestra holds a patent on the use of urine-isolated cells for the production of hiPSCs and the necessary know-how.
Services / Products:
- Finding donors of interest (healthy donors or patients)
- Producing hiPSCs from cells isolated from urine samples from these donors
- Manufacture of cell banks
- Cultivation of large cell counts ([gt]109)
- Production of exosome preparations (extracellular vesicles)
